Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain
Maryam B. Lustberg(Yale Cancer Center), Martha A. Belury(The Ohio State University), Charles L. Loprinzi(Mayo Clinic in Arizona), Tonya Orchard(The Ohio State University), Xueliang Pan(The Ohio State University), Robert Wesolowski(The Ohio State University Wexner Medical Center), Amanda Logan(The Ohio State University), Rebecca Andridge(The Ohio State University), Charles L. Shapiro(Tisch Hospital), Bhuvaneswari Ramaswamy(The Ohio State University), Michael Berger(Memorial Sloan Kettering Cancer Center), Raquel E. Reinbolt(The Ohio State University), Rachel Layman(The Ohio State University), Rachel M. Cole(The Ohio State University), Elaine Patterson(University College Cork)
Cited by 37
Related Papers
Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat
|Journal of Psychiatric Research|2016|1.7k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Differences in Breast Cancer Survival by Molecular Subtypes in the United States
|Cancer Epidemiology Biomarkers & Prevention|2018|604
Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline
|Journal of Clinical Oncology|2005|565